FARNUM RHONDA (SVP, Comm & Medical Affairs) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2026ACC: 0001898490-26-000002
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-13.93K
Net shares
Net seller
$273.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.93K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−13.93K
Price / share
$19.66
Trade value
$273.84K
% of position
5.0%
2/20/2026
277.69K→263.77K
Total
Net shares
−13.93K
Net value
-$273.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2026 | F · Tax Withholding | −13.93K | $19.66 | $273.84K | 5.0% | 277.69K | 263.77K |
| Total | −13.93K | -$273.84K | ||||||
Derivative Transactions0
No derivative transactions reported